Chart · view recorded under the Health care operations purpose
Withheld from this view and from assistant retrieval:
1 × Reproductive health.
Sensitive-category records exist and are counted, never silently absent — reaching
them takes the dedicated role and path, and every access is audited as a disclosure.
Your psychotherapy role can open the notes below.
Active problems
| Condition | Status | Onset |
| Prediabetes (finding) |
active |
Sep 18, 2026 |
| Body mass index 30+ - obesity (finding) |
active |
Feb 27, 2023 |
| Type 2 diabetes mellitus (disorder) |
active |
Feb 1, 2014 |
Active medications
| Medication | Dosage | Since |
| Empagliflozin 10 MG Oral Tablet | 10 mg daily |
Nov 6, 2026 |
Allergies
| Substance | Reaction | Verification |
| Shellfish | Swelling |
confirmed |
Recent results
| Test | Value | When |
| Creatinine |
1.1 mg/dL |
Nov 18, 2026 |
| Systolic blood pressure |
148.8 mmHg |
Oct 17, 2026 |
| LDL cholesterol |
92.4 mg/dL |
Sep 26, 2026 |
| Systolic blood pressure |
146.9 mmHg |
Aug 16, 2026 |
| Systolic blood pressure |
137.1 mmHg |
Aug 25, 2025 |
| Systolic blood pressure abnormal |
168.4 mmHg |
Aug 9, 2025 |
| Glucose abnormal |
76.3 mg/dL |
Jan 11, 2025 |
| Oxygen saturation abnormal |
98.9 % |
Dec 2, 2024 |
| Systolic blood pressure |
154.8 mmHg |
Nov 18, 2024 |
| Hemoglobin A1c |
5.2 % |
Oct 12, 2024 |
| Heart rate |
65 /min |
Sep 7, 2024 |
| Heart rate |
99.8 /min |
Jul 26, 2024 |
| LDL cholesterol |
119.4 mg/dL |
Apr 22, 2024 |
| Hemoglobin |
15.3 g/dL |
Mar 18, 2024 |
| Hemoglobin A1c |
8 % |
Feb 5, 2023 |
Notes & documents
| Document | Author | Date | |
| No unrestricted documents. |
Claims
| Claim | Payer | Date | Status |
Billed | Paid | |
| CLM-G0107697 | Medicare |
Aug 11, 2024 |
paid |
$111.60 |
$91.12 |
Lines |